Sorafenib: Drug Summary  
Name Sorafenib
Chemical formula C21H16CIF3N4O3 
Chemical structure
Administration route Oral
Dosage 400 mg b.i.d.
Indication 2005: FDA approval for advanced renal cell carcinoma. 2006:  Marketing authorization given by the  European Commission for renal cell carcinoma. 2007: Marketing authorization given by the European Commission for hepatocellular carcinoma; FDA approval for hepatocellular carcinoma.
Table 1: Drug summary about sorafenib.